I
Inhibrx Biosciences Inc.
INBX · NASDAQ · Healthcare · 1.3B
Price · close
$103.63
+4.52% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
200.8×
Enterprise value / EBITDAEV/EBITDA
-12.7×
Free cash flow yieldFCF yield
-8.1%
Return on equityROE
-1752.2%
Operating margin
-10386.5%
Net debt / EBITDAbalance-sheet strength
0.1×
Interest coverage
-11.1×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.